before few years, the united kingdom has witnessed a revolution in healthcare fat‑reduction treatments — through the introduction of semaglutide (Wegovy®) for the developing acceptance of tirzepatide (Mounjaro®). Now, An additional name is drawing interest in both of those medical and general pub